Blog

If you were invested in the stock market in 2019, you're probably grinning from ear to ear. When the curtain closed on the year, the benchmark S&P 500 had gained 29%, with the tech-heavy Nasdaq and

Image source: The Motley Fool.

Infosys Limited (NYSE: INFY)Q3 2020 Earnings CallJan 10, 2020, 7:45 a.m. ET

Operator

Continue reading

Source Fool.com

Way back in 2013, iRobot (NASDAQ: IRBT) founder, chairman and CEO Colin Angle mused in an interview with The Verge that robotic butlers were still a decade away. Later that year, when asked by

Shares of CoStar Group (NASDAQ: CSGP), which provides data and marketing services to the multifamily and commercial real estate industry, rocketed 77.4% in 2019, according to data from S&P Global

A new lawsuit is claiming that top tech stock Apple (NASDAQ: AAPL) infringed patented technology to use in its Apple Watch. The suit was brought by Masimo (NASDAQ: MASI), in league with its spinoff

California's Adult Use of Marijuana Act, or Proposition 64, legalizing marijuana was passed in 2016. However, legal marijuana sales at dispensaries still only account for about one-quarter of all

Shares in less-than-truckload (LTL) shipping company Old Dominion Freight Line (NASDAQ: ODFL) soared 53.7% in 2019, according to data provided by S&P Global Market Intelligence. The move is

Shares of Dutch electronics and medical devices giant Royal Philips (NYSE: PHG) rose 39% in 2019, according to data from S&P Global Market Intelligence. The company experienced more ups than downs

Shares of Brookfield Asset Management (NYSE: BAM) gained 50.7% last year, according to data provided by S&P Global Market Intelligence. That beat the S&P 500 index return of 28.9%. 

Brookfield

Shares in electronic test and measurement tools company MKS Instruments (NASDAQ: MKSI) rose 70.3% in 2019, according to data provided by S&P Global Market Intelligence. The move is part of a general

In this episode of MarketFoolery, host Chris Hill talks with analyst Abi Malin about some recent business news. Costco (NASDAQ: COST) popped on better-than-expected results, and its long-term

After disclosing the latest data for its gene therapy DTX301 in ornithine transcarbamylase (OTC) deficiency, Ultragenyx Pharmaceutical (NASDAQ: RARE) saw its shares gain 13.4% on Friday.

Ultragenyx

Shares of Thermo Fisher Scientific (NYSE: TMO) lept over 45% last year, according to data provided by S&P Global Market Intelligence. The scientific-research products monopoly didn't do anything

In this episode of MarketFoolery, host Chris Hill talks with analyst Bill Mann about some recent business news. Boeing's (NYSE: BA) stock is in trouble after a disastrous crash of one of its

Pity shareholders in Aurora Cannabis (NYSE: ACB), once a highflier on the cannabis scene.

In a one-two punch to investor sentiment on Thursday, analysts at investment bank Piper Sandler cut their

Shares of infrastructure company MasTec (NYSE: MTZ) soared by 58.2% in 2019 according to data provided by S&P Global Market Intelligence. Those gains reflected the upgrades to its earnings outlook

Shares of Advanced Micro Devices (NASDAQ: AMD) rose 148.4% in 2019, according to data from S&P Global Market Intelligence. The chip designer held on to a rare manufacturing process lead over

Marijuana stock Aurora Cannabis (NYSE: ACB) is trading down by more than 10% on Friday, following a highly critical analysis from an investment bank.

Late Thursday, Piper Sandler published a note

Just one day after the stock plunged 19% on an ugly earnings report, Bed Bath and Beyond (NASDAQ: BBBY) was recovering some of those losses today, a sign investors think the stock was oversold after

Shares of Universal Display (NASDAQ: OLED) gained 120% in 2019, according to data from S&P Global Market Intelligence. The technology developer and materials reseller behind organic light-emitting

Shares of Nektar Therapeutics (NASDAQ: NKTR) rose nearly 20% today after the company announced a new development plan with Bristol-Myers Squibb (NYSE: BMY). 

The collaboration will advance

Shares of Matinas Biopharma (NYSEMKT: MTNB) fell over 23% today after the company announced the pricing of a public stock offering. The clinical-stage pharmaceutical specialist will offer up to 37.1

Image source: The Motley Fool.

Pricesmart Inc (NASDAQ: PSMT)Q1 2020 Earnings CallJan 10, 2020, 12:00 p.m. ET

Operator

Continue reading

Source Fool.com

The Dow Jones Industrial Average (DJINDICES: ^DJI) had taken a dive by 11:30 a.m. EST Friday, down 0.23%. A weaker-than-expected December jobs report may be playing a role. The U.S. added 145,000

Shares of data analysis expert Splunk (NASDAQ: SPLK) rose 42.8% in 2019, according to data from S&P Global Market Intelligence. The company beat Wall Street's earnings and revenue expectations in